Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion type Assertion NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_head.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion description "[Estimation of CT7, also referred to as MAGE-C1, immunoreactivity is of limited prognostic usefulness in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_provenance.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion evidence source_evidence_literature NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_provenance.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion SIO_000772 17607369 NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_provenance.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion wasDerivedFrom lhgdn-20090331 NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_provenance.
- NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_assertion wasGeneratedBy ECO_0000203 NP226813.RAJ-0taQ8-AnAskS3qVlVe1sJnCfK6ftJOG9xHuQbiMe0130_provenance.